CL2007001499A1 - Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes - Google Patents
Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetesInfo
- Publication number
- CL2007001499A1 CL2007001499A1 CL2007001499A CL2007001499A CL2007001499A1 CL 2007001499 A1 CL2007001499 A1 CL 2007001499A1 CL 2007001499 A CL2007001499 A CL 2007001499A CL 2007001499 A CL2007001499 A CL 2007001499A CL 2007001499 A1 CL2007001499 A1 CL 2007001499A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- pyrrolidinaminoacetylpyrrolidinboronic
- dpp
- diabetes
- citrate
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de un antígeno de lawsonia intracellularis para la vacunación de un animal joven contra infecciones contra este microorganismo o un animal que tiene anticuerpos contra este microorganismo o que se ha expuesto a estos anticuerpos.Use of a lawsonia intracellularis antigen for the vaccination of a young animal against infections against this microorganism or an animal that has antibodies against this microorganism or has been exposed to these antibodies.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80320706P | 2006-05-25 | 2006-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007001499A1 true CL2007001499A1 (en) | 2008-01-18 |
Family
ID=39722421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2007001499A CL2007001499A1 (en) | 2006-05-25 | 2007-05-24 | Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN101454020A (en) |
AR (1) | AR061201A1 (en) |
CL (1) | CL2007001499A1 (en) |
TW (1) | TW200815027A (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8102786A (en) * | 1981-06-10 | 1983-01-03 | Duphar Int Res | METHOD FOR IMMUNIZING PIGS AGAINST AUJESZKY'S DISEASE |
-
2007
- 2007-05-24 CN CNA200780019257XA patent/CN101454020A/en active Pending
- 2007-05-24 TW TW96118584A patent/TW200815027A/en unknown
- 2007-05-24 CL CL2007001499A patent/CL2007001499A1/en unknown
- 2007-05-28 AR ARP070102286A patent/AR061201A1/en not_active Suspension/Interruption
Also Published As
Publication number | Publication date |
---|---|
TW200815027A (en) | 2008-04-01 |
AR061201A1 (en) | 2008-08-13 |
CN101454020A (en) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115751T1 (en) | PHARMACEUTICAL COMBINATION 3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOLIS AND AN ANTIPEXIL | |
EA201170772A1 (en) | ORGANIC COMPOUNDS | |
CL2010000188A1 (en) | A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use. | |
EA201490815A1 (en) | ETHERACEPT COMPOSITIONS, STABILIZED BY AMINO ACIDS | |
AR063429A1 (en) | ANTI-HTNFALFA CRISTALINOS ANTIBODIES | |
UY32062A (en) | BETA-SECRETASA INHIBITORS | |
CY1115893T1 (en) | ANTI-PREVENTIVE PYRAMIDINES AND THEIR USES | |
ES2488407T3 (en) | Pharmaceutical preparation containing lipase of bacterial origin | |
CL2012001348A1 (en) | Hemitartrate crystal salt of compound genz-112638, glucosylceramide synthetase inhibitor; pharmaceutical composition comprising it, and its use in the treatment of gaucher disease and fabry disease. | |
BRPI0715396B8 (en) | method of producing a vaccine composition | |
EA201791850A1 (en) | Boron-containing small molecules | |
BRPI0906478B8 (en) | anti-nr10 antibody, its use and pharmaceutical composition comprising it | |
AR084285A1 (en) | IMMUNOGENIC COMPOSITIONS | |
CL2008002076A1 (en) | Compounds derived from substituted aryloxazoles; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat diabetes, metabolic syndrome, dyslipidemias, among other diseases. | |
CL2008001783A1 (en) | Deoxycholic acid (dca); pharmaceutical composition comprising it; deoxycolic acid preparation process; intermediate compounds, useful in the preparation of a drug to remove fat deposits. | |
MX2008013619A (en) | Augmentation of titer for vaccination in animals. | |
EA200970605A1 (en) | MAPK / ERK KINAZ INHIBITORS | |
CL2012002422A1 (en) | Method for treating active lupus arthritis which comprises administering the patient laquinimod or its sodium salt orally. | |
CY1109916T1 (en) | Benzimidazolo-thiophene compounds as PLK inhibitors | |
DK201100184U1 (en) | Method for immunizing an avian species | |
DE602006017724D1 (en) | salicylic acid derivatives | |
CY1111367T1 (en) | NEW PRODUCTS OF DIOMETIN, THEIR METHOD OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR079050A1 (en) | BENZOIMIDAZOLIC COMPOUNDS AND THEIR USES | |
NO20084320L (en) | Antibodies to EGFL7 and methods for their use | |
AR096705A1 (en) | COMPOSITION THAT INCLUDES GLUTAMIC ACID-N, N-DIACETATE (GLDA), WATER AND ENZYME |